Fifth Third Bancorp Neurocrine Biosciences Inc Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 819 shares of NBIX stock, worth $112,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares

819

Previous 1,056 22.44%

Holding current value

$112,227

Previous $116,000 12.07%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$87.54 - $128.18 $20,746 - $30,378	-237 Reduced 22.44%	819 $102,000
Q1 2025 Apr 15, 2025	BUY	$107.22 - $153.29 $27,233 - $38,935	254 Added 31.67%	1,056 $116,000
Q4 2024 Jan 21, 2025	SELL	$111.62 - $139.44 $223 - $278	-2 Reduced 0.25%	802 $109,000
Q3 2024 Oct 17, 2024	BUY	$114.58 - $153.15 $10,083 - $13,477	88 Added 12.29%	804 $92,000
Q2 2024 Jul 22, 2024	BUY	$130.86 - $143.19 $12,039 - $13,173	92 Added 14.74%	716 $98,000
Q1 2024 Apr 23, 2024	BUY	$130.4 - $143.74 $4,172 - $4,599	32 Added 5.41%	624 $86,000
Q4 2023 Jan 19, 2024	SELL	$106.07 - $132.76 $3,182 - $3,982	-30 Reduced 4.82%	592 $78,000
Q3 2023 Oct 31, 2023	BUY	$94.02 - $117.1 $19,838 - $24,708	211 Added 51.34%	622 $69,000
Q2 2023 Jul 25, 2023	BUY	$89.53 - $104.87 $5,550 - $6,501	62 Added 17.77%	411 $38,000
Q1 2023 Apr 24, 2023	BUY	$94.11 - $123.02 $4,517 - $5,904	48 Added 15.95%	349 $35,000
Q4 2022 Jan 25, 2023	SELL	$106.72 - $127.06 $1,600 - $1,905	-15 Reduced 4.75%	301 $0
Q3 2022 Oct 25, 2022	SELL	$92.03 - $107.81 $9,479 - $11,104	-103 Reduced 24.58%	316 $34,000
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $7,730 - $10,207	102 Added 32.18%	419 $41,000
Q1 2022 Apr 19, 2022	BUY	$72.45 - $94.81 $4,999 - $6,541	69 Added 27.82%	317 $30,000
Q3 2021 Oct 15, 2021	BUY	$86.18 - $99.03 $20,510 - $23,569	238 Added 2380.0%	248 $24,000
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $894 - $1,022	10 New	10 $1,000
Q2 2020 Aug 05, 2020	SELL	$85.09 - $130.36 $8,849 - $13,557	-104 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$75.11 - $113.76 $1,351 - $2,047	-18 Reduced 14.75%	104 $9,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $1,562 - $2,134	18 Added 17.31%	122 $13,000
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $75,102 - $90,944	-896 Reduced 89.6%	104 $9,000
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $69,240 - $91,438	999 Added 99900.0%	1,000 $88,000
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $6,012 - $10,943	-88 Reduced 98.88%	1 $0
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $7,613 - $9,690	-77 Reduced 46.39%	89 $11,000
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $13,354 - $16,267	-176 Reduced 51.46%	166 $14,000
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $22,943 - $30,415	-392 Reduced 53.41%	342 $27,000
Q3 2017 Nov 14, 2017	SELL	$47.97 - $61.28 $10,793 - $13,788	-225 Reduced 23.46%	734 $45,000
Q2 2017 Aug 11, 2017	BUY	N/A	959	959 $44,000

Others Institutions Holding NBIX

# of Institutions

657

Shares Held

101M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Neurocrine Biosciences Inc Transaction History